Recruiting

Who we are

  • April 5, 2022
    REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors
  • April 5, 2022
    Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
  • April 5, 2022
    Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
  • April 5, 2022
    A Study of NX-1607 in Adults With Advanced Malignancies
  • April 5, 2022
    PG545 (pixatimod) in combination with nivolumab
  • April 5, 2022
    Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
  • April 5, 2022
    Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies
  • April 5, 2022
    Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
  • April 5, 2022
    CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
  • April 5, 2022
    Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal Cancer